[DPHARMA] YoY Annualized Quarter Result on 31-Dec-2009 [#4]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
23-Feb-2010
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2009
Quarter
31-Dec-2009 [#4]
Profit Trend
QoQ- 1.28%
YoY- 10.33%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 CAGR
Revenue 135,310 138,132 131,437 123,766 122,872 115,551 105,100 4.29%
PBT 35,298 34,728 35,408 38,215 35,340 42,587 38,094 -1.26%
Tax -9,284 -8,023 -6,739 -7,982 -7,937 -10,544 -9,115 0.30%
NP 26,014 26,705 28,669 30,233 27,403 32,043 28,979 -1.78%
-
NP to SH 26,014 26,705 28,669 30,233 27,403 32,043 28,979 -1.78%
-
Tax Rate 26.30% 23.10% 19.03% 20.89% 22.46% 24.76% 23.93% -
Total Cost 109,296 111,427 102,768 93,533 95,469 83,508 76,121 6.20%
-
Net Worth 169,354 163,783 156,881 142,975 130,490 113,794 144,270 2.70%
Dividend
31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 CAGR
Div 19,434 24,983 222 24,985 20,822 66,611 29,825 -6.88%
Div Payout % 74.71% 93.56% 0.77% 82.64% 75.99% 207.88% 102.92% -
Equity
31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 CAGR
Net Worth 169,354 163,783 156,881 142,975 130,490 113,794 144,270 2.70%
NOSH 138,815 138,799 138,832 138,810 138,819 138,774 138,721 0.01%
Ratio Analysis
31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 CAGR
NP Margin 19.23% 19.33% 21.81% 24.43% 22.30% 27.73% 27.57% -
ROE 15.36% 16.31% 18.27% 21.15% 21.00% 28.16% 20.09% -
Per Share
31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 CAGR
RPS 97.47 99.52 94.67 89.16 88.51 83.27 75.76 4.28%
EPS 18.74 19.24 20.65 21.78 19.74 23.09 20.89 -1.79%
DPS 14.00 18.00 0.16 18.00 15.00 48.00 21.50 -6.89%
NAPS 1.22 1.18 1.13 1.03 0.94 0.82 1.04 2.69%
Adjusted Per Share Value based on latest NOSH - 138,831
31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 CAGR
RPS 14.07 14.36 13.66 12.87 12.77 12.01 10.93 4.29%
EPS 2.70 2.78 2.98 3.14 2.85 3.33 3.01 -1.79%
DPS 2.02 2.60 0.02 2.60 2.16 6.92 3.10 -6.88%
NAPS 0.1761 0.1703 0.1631 0.1486 0.1357 0.1183 0.15 2.70%
Price Multiplier on Financial Quarter End Date
31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 CAGR
Date 31/12/12 30/12/11 30/12/10 31/12/09 31/12/08 31/12/07 29/12/06 -
Price 2.13 2.02 2.39 2.40 2.08 2.60 2.47 -
P/RPS 2.19 2.03 2.52 2.69 2.35 3.12 3.26 -6.40%
P/EPS 11.37 10.50 11.57 11.02 10.54 11.26 11.82 -0.64%
EY 8.80 9.52 8.64 9.08 9.49 8.88 8.46 0.65%
DY 6.57 8.91 0.07 7.50 7.21 18.46 8.70 -4.56%
P/NAPS 1.75 1.71 2.12 2.33 2.21 3.17 2.38 -4.99%
Price Multiplier on Announcement Date
31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 CAGR
Date 25/02/13 22/02/12 23/02/11 23/02/10 24/02/09 21/02/08 22/02/07 -
Price 2.17 2.12 2.45 2.33 2.20 2.53 2.54 -
P/RPS 2.23 2.13 2.59 2.61 2.49 3.04 3.35 -6.55%
P/EPS 11.58 11.02 11.86 10.70 11.14 10.96 12.16 -0.81%
EY 8.64 9.08 8.43 9.35 8.97 9.13 8.22 0.83%
DY 6.45 8.49 0.07 7.73 6.82 18.97 8.46 -4.41%
P/NAPS 1.78 1.80 2.17 2.26 2.34 3.09 2.44 -5.11%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment